| Dr Michael R Catena, MD | |
|
907 Washington Ave, Carnegie, PA 15106-3215 | |
| (412) 279-2900 | |
| (412) 279-2012 |
| Full Name | Dr Michael R Catena |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 52 Years |
| Location | 907 Washington Ave, Carnegie, Pennsylvania |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1497707467 | NPI | - | NPPES |
| 063646 | Medicaid | PA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | MD037114-L (Pennsylvania) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| St Clair Hospital | Pittsburgh, PA | Hospital |
| Entity Name | Family Practice Medical Center, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1942242631 PECOS PAC ID: 2264470756 Enrollment ID: O20050425000869 |
News Archive
Ipsen announced today that the Food and Drug Administration (FDA) has approved Ipsen's Prior Approval Supplement application for the Extended Dosing Interval of Somatuline® Depot for patients suffering from acromegaly.
Neuralstem, Inc. announced today that it has entered into definitive agreements to sell $10 million of units at $2.80 per unit in a registered-direct offering to institutional investors. The units consist of: (i) one share of common stock, and (ii) 3/4 common stock purchase warrant. The warrants have an exercise price of $3.25 and a term of three years.
By 2025 some 500 million people will be living with osteoporosis, a chronic disease which weakens bones and leaves older adults at risk of a fragility fracture - a broken bone which typically occurs after a low-trauma fall. As a result, an estimated 13.5 million fragility fractures will occur worldwide.
Naurex Inc. today announced that the U.S. Food and Drug Administration has granted Fast Track designation to the investigation of GLYX-13, the company's rapid-acting antidepressant in Phase 2 clinical development, as adjunctive therapy in major depressive disorder.
Throughout the pandemic, infectious disease experts and frontline medical workers have asked for a faster, cheaper and more reliable COVID-19 test.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Michael R Catena, MD 907 Washington Ave, Carnegie, PA 15106-3215 Ph: (412) 279-2900 | Dr Michael R Catena, MD 907 Washington Ave, Carnegie, PA 15106-3215 Ph: (412) 279-2900 |
News Archive
Ipsen announced today that the Food and Drug Administration (FDA) has approved Ipsen's Prior Approval Supplement application for the Extended Dosing Interval of Somatuline® Depot for patients suffering from acromegaly.
Neuralstem, Inc. announced today that it has entered into definitive agreements to sell $10 million of units at $2.80 per unit in a registered-direct offering to institutional investors. The units consist of: (i) one share of common stock, and (ii) 3/4 common stock purchase warrant. The warrants have an exercise price of $3.25 and a term of three years.
By 2025 some 500 million people will be living with osteoporosis, a chronic disease which weakens bones and leaves older adults at risk of a fragility fracture - a broken bone which typically occurs after a low-trauma fall. As a result, an estimated 13.5 million fragility fractures will occur worldwide.
Naurex Inc. today announced that the U.S. Food and Drug Administration has granted Fast Track designation to the investigation of GLYX-13, the company's rapid-acting antidepressant in Phase 2 clinical development, as adjunctive therapy in major depressive disorder.
Throughout the pandemic, infectious disease experts and frontline medical workers have asked for a faster, cheaper and more reliable COVID-19 test.
› Verified 2 days ago
Jared Carl Bovalino, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2375 Greentree Rd, Carnegie, PA 15106 Phone: 412-276-1560 Fax: 412-276-5805 | |
Mr. Joseph Isaac Trompeter, MD FAAP Family Medicine Medicare: Medicare Enrolled Practice Location: 813 Washington Ave, Carnegie, PA 15106 Phone: 412-276-2203 Fax: 412-276-3355 | |
Frank Civitarese, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2375 Greentree Rd, Carnegie, PA 15106 Phone: 412-276-1560 Fax: 412-276-5805 | |
Louis Civitarese, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2375 Greentree Rd, Carnegie, PA 15106 Phone: 412-276-1560 Fax: 412-276-5805 |